Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immunic, Inc. (IMUX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immunic, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1280776.
Total stock buying since 2015: $21,286,874.
Total stock sales since 2015: $4,502,304.
Total stock option exercises since 2015: $54,952.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 165,000 | $125,485 | 0 | $0 | 0 | $0 |
| 2024 | 87,300 | $100,394 | 0 | $0 | 0 | $0 |
| 2023 | 5,000 | $8,750 | 0 | $0 | 0 | $0 |
| 2022 | 56,000 | $152,842 | 0 | $0 | 0 | $0 |
| 2021 | 18,506 | $257,148 | 0 | $0 | 0 | $0 |
| 2020 | 1,000 | $18,960 | 11,950 | $174,863 | 0 | $0 |
| 2019 | 0 | $0 | 4,400 | $30,624 | 22,157 | $0 |
| 2018 | 0 | $0 | 11,778,631 | $4,296,817 | 0 | $0 |
| 2017 | 4,353,600 | $17,591,103 | 0 | $0 | 0 | $0 |
| 2016 | 118,243 | $699,998 | 0 | $0 | 0 | $0 |
| 2015 | 426,885 | $2,332,194 | 0 | $0 | 128,394 | $54,952 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 165,000 | $125,485 | 0 | $0 | 0 | $0 |
| 2024-11 | 87,300 | $100,394 | 0 | $0 | 0 | $0 |
| 2023-05 | 5,000 | $8,750 | 0 | $0 | 0 | $0 |
| 2022-11 | 31,000 | $43,295 | 0 | $0 | 0 | $0 |
| 2022-06 | 8,500 | $26,157 | 0 | $0 | 0 | $0 |
| 2022-05 | 16,500 | $83,390 | 0 | $0 | 0 | $0 |
| 2021-08 | 3,500 | $34,175 | 0 | $0 | 0 | $0 |
| 2021-05 | 4,000 | $51,000 | 0 | $0 | 0 | $0 |
| 2021-03 | 11,006 | $171,973 | 0 | $0 | 0 | $0 |
| 2020-08 | 1,000 | $18,960 | 0 | $0 | 0 | $0 |
| 2020-07 | 0 | $0 | 11,950 | $174,863 | 0 | $0 |
| 2019-12 | 0 | $0 | 4,400 | $30,624 | 22,157 | $0 |
| 2018-09 | 0 | $0 | 11,778,631 | $4,296,817 | 0 | $0 |
| 2017-12 | 250,000 | $1,281,500 | 0 | $0 | 0 | $0 |
| 2017-09 | 249,200 | $985,669 | 0 | $0 | 0 | $0 |
| 2017-06 | 104,400 | $323,934 | 0 | $0 | 0 | $0 |
| 2017-03 | 3,750,000 | $15,000,000 | 0 | $0 | 0 | $0 |
| 2016-08 | 118,243 | $699,998 | 0 | $0 | 0 | $0 |
| 2015-10 | 412,885 | $2,289,020 | 0 | $0 | 0 | $0 |
| 2015-09 | 14,000 | $43,174 | 0 | $0 | 128,394 | $54,952 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-13 | Nash Duane (Executive Chairman) | Buy | 20,000 | .83 | 16,700 |
| 2025-06-05 | Neermann Joerg | Buy | 30,000 | .76 | 22,800 |
| 2025-06-04 | Neermann Joerg | Buy | 70,000 | .77 | 53,900 |
| 2025-06-03 | Whaley Glenn (Chief Financial Officer) | Buy | 45,000 | .71 | 32,085 |
| 2024-11-12 | Rudick Richard Alan | Buy | 87,300 | 1.15 | 100,394 |
| 2023-05-15 | Whaley Glenn (Chief Financial Officer) | Buy | 5,000 | 1.75 | 8,750 |
| 2022-11-23 | Neermann Joerg | Buy | 18,000 | 1.39 | 25,020 |
| 2022-11-22 | Vitt Daniel (President and CEO) | Buy | 8,000 | 1.35 | 10,800 |
| 2022-11-07 | Whaley Glenn (Chief Financial Officer) | Buy | 5,000 | 1.50 | 7,475 |
| 2022-06-03 | Vitt Daniel (President and CEO) | Buy | 5,000 | 3.10 | 15,500 |
| 2022-06-03 | Whaley Glenn (Chief Financial Officer) | Buy | 3,500 | 3.04 | 10,657 |
| 2022-05-12 | Muehler Andreas (Chief Medical Officer) | Buy | 3,500 | 5.10 | 17,850 |
| 2022-05-12 | Whaley Glenn (Chief Financial Officer) | Buy | 3,000 | 5.08 | 15,240 |
| 2022-05-12 | Nash Duane (Executive Chairman) | Buy | 10,000 | 5.03 | 50,300 |
| 2021-08-10 | Vitt Daniel (President and CEO) | Buy | 1,000 | 9.60 | 9,600 |
| 2021-08-10 | Whaley Glenn (PFO and PAO) | Buy | 1,500 | 9.85 | 14,775 |
| 2021-08-10 | Nash Duane (Executive Chairman) | Buy | 1,000 | 9.80 | 9,800 |
| 2021-05-12 | Nash Duane (Executive Chairman) | Buy | 4,000 | 12.75 | 51,000 |
| 2021-03-02 | Muehler Andreas (Chief Medical Officer) | Buy | 10,006 | 15.54 | 155,493 |
| 2021-03-02 | Whaley Glenn (PFO and PAO) | Buy | 1,000 | 16.48 | 16,480 |
| 2020-08-10 | Whaley Glenn (PFO and PAO) | Buy | 1,000 | 18.96 | 18,960 |
| 2020-07-21 | Groeppel Manfred (Chief Operating Officer) | Sale | 650 | 15.62 | 10,154 |
| 2020-07-21 | Vitt Daniel (Chief Executive Officer) | Sale | 1,300 | 15.62 | 20,309 |
| 2020-07-20 | Groeppel Manfred (Chief Operating Officer) | Sale | 5,000 | 14.44 | 72,200 |
| 2020-07-20 | Vitt Daniel (Chief Executive Officer) | Sale | 5,000 | 14.44 | 72,200 |
| 2019-12-04 | Nash Duane | Sale | 4,400 | 6.96 | 30,624 |
| 2019-12-02 | Nash Duane | Option Ex | 22,157 | .00 | 0 |
| 2018-09-25 | Halperin Errol R. | Sale | 99,417 | .29 | 28,830 |
| 2018-09-24 | Bienaime Jean Jacques | Sale | 26,619 | .30 | 8,012 |
| 2018-09-19 | Godshall Douglas Evan | Sale | 69,375 | .35 | 24,211 |
| 2018-09-17 | Satter Muneer A | Sale | 7,044,777 | .29 | 2,057,074 |
| 2018-09-14 | Satter Muneer A | Sale | 447,500 | .36 | 160,205 |
| 2018-09-13 | Hasnain Faheem | Sale | 177,443 | .44 | 77,720 |
| 2018-09-13 | Satter Muneer A | Sale | 3,890,000 | .50 | 1,929,440 |
| 2018-09-13 | Bienaime Jean Jacques | Sale | 20,000 | .47 | 9,400 |
| 2018-09-12 | Cohen Cheryl | Sale | 3,500 | .55 | 1,925 |
| 2017-12-13 | Satter Muneer A | Buy | 50,000 | 5.57 | 278,550 |
| 2017-12-12 | Satter Muneer A | Buy | 50,000 | 5.39 | 269,750 |
| 2017-12-11 | Satter Muneer A | Buy | 50,000 | 4.96 | 248,250 |
| 2017-12-08 | Satter Muneer A | Buy | 50,000 | 4.92 | 246,200 |
| 2017-12-07 | Satter Muneer A | Buy | 50,000 | 4.78 | 238,750 |
| 2017-09-14 | Hasnain Faheem | Buy | 59,200 | 4.19 | 247,870 |
| 2017-09-14 | Satter Muneer A | Buy | 30,000 | 4.25 | 127,530 |
| 2017-09-13 | Satter Muneer A | Buy | 50,000 | 4.13 | 206,449 |
| 2017-09-13 | Bienaime Jean Jacques | Buy | 10,000 | 4.00 | 39,970 |
| 2017-09-12 | Satter Muneer A | Buy | 50,000 | 3.75 | 187,250 |
| 2017-09-08 | Satter Muneer A | Buy | 50,000 | 3.53 | 176,600 |
| 2017-06-14 | Winters Terence E. (Co-Chairman and CEO) | Buy | 10,000 | 3.10 | 30,980 |
| 2017-06-14 | Satter Muneer A | Buy | 10,000 | 3.10 | 31,010 |
| 2017-06-14 | Dunn John Michael (General Counsel and Secretary) | Buy | 2,500 | 3.08 | 7,707 |
| 2017-06-13 | Satter Muneer A | Buy | 10,000 | 3.03 | 30,310 |
| 2017-06-13 | Bienaime Jean Jacques | Buy | 16,000 | 3.00 | 48,064 |
| 2017-06-12 | Satter Muneer A | Buy | 10,000 | 3.06 | 30,620 |
| 2017-06-09 | Ashley Robert A. (Chief Technical Officer, EVP) | Buy | 2,000 | 3.18 | 6,360 |
| 2017-06-09 | Satter Muneer A | Buy | 10,000 | 3.17 | 31,730 |
| 2017-06-08 | Nash Duane (President) | Buy | 3,900 | 3.12 | 12,183 |
| 2017-06-08 | Satter Muneer A | Buy | 10,000 | 3.10 | 30,960 |
| 2017-06-07 | Satter Muneer A | Buy | 10,000 | 3.21 | 32,070 |
| 2017-06-06 | Satter Muneer A | Buy | 10,000 | 3.19 | 31,940 |
| 2017-03-27 | Satter Muneer A | Buy | 3,750,000 | 4.00 | 15,000,000 |
| 2016-08-12 | Hasnain Faheem | Buy | 118,243 | 5.92 | 699,998 |
| 2015-10-28 | Satter Muneer A | Buy | 400,000 | 5.50 | 2,200,000 |
| 2015-10-26 | Cohen Cheryl | Buy | 3,500 | 7.17 | 25,091 |
| 2015-10-26 | Dunn John Michael (General Counsel and Secretary) | Buy | 2,000 | 7.00 | 14,000 |
| 2015-10-23 | Dunn John Michael (General Counsel and Secretary) | Buy | 7,385 | 6.76 | 49,929 |
| 2015-09-14 | Winters Terence E. (Co-Chairman and CEO) | Option Ex | 128,394 | .43 | 54,952 |
| 2015-09-10 | Bienaime Jean Jacques (Director) | Buy | 6,000 | 3.05 | 18,294 |
| 2015-09-09 | Bienaime Jean Jacques (Director) | Buy | 8,000 | 3.11 | 24,880 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMUX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immunic, Inc. (symbol IMUX, CIK number 1280776) see the Securities and Exchange Commission (SEC) website.